INNOVATIONS in Pharmacy (Apr 2017)

Atypical Antipsychotic-Induced Parkinsonism: A Patient Case with CYP Enzyme Implications

  • Carla Dolci Figura,
  • Michael Schuh

DOI
https://doi.org/10.24926/iip.v8i2.507
Journal volume & issue
Vol. 8, no. 2

Abstract

Read online

Objective: To report a case of Parkinsonism potentially caused by neuroleptic medications. Summary: The case analyzed is that of a 57-year-old male patient referred to a pharmacotherapy service by a neurologist after organic causes of tremor had been ruled out. Iatrogenic cause was suspected and referral expectation was to identify the offending agent or agents and propose alternative therapy. Conclusion: This case illustrates iatrogenic risk associated with neuroleptic medications while illustrating mechanisms of drug interaction via CYP enzymes that can lead to iatrogenic disease. Abbreviations: DIP = Drug-induced Parkinsonism; MTM = Medication Therapy Management; PD = Parkinson’s Disease Type: Clincial Experience

Keywords